Pediatric melanomas are often misdiagnosed by physicians. Adolescents have a more aggressive disease course than children and are treated with adult protocols leading to chronic morbidity.
Oral propranolol may be safe for infants with uncomplicated hemangiomas, but for those with underlying health conditions, it may not always be the treatment of choice.
Observational study shows high heart disease risk in severe and predominantly active atopic eczema.
Skin biopsies from infants with atopic dermatitis feature important differences compared to adults with atopic dermatitis. These differences could change atopic dermatitis treatment for infants and toddlers with the disease, a study shows.
The fixed combination of halobetasol and tazarotene topicals significantly reduced the severity of localized disease with a favorable safety profile, shows a study published in the Journal of the American Academy of Dermatology.
Three patients achieve 80-100 percent clearance of moderate-to-severe dyshidrosis of the hands and palms after treatment with dupilumab.
Symptomatic relief remains out of reach for many who suffer chronic pruritis. Without drugs specifically approved to treat chronic itch, providers and patients rely on therapies with limited efficacy. Here’s an update of two important clinical trials.
Spanish researchers have developed a scoring system to assess the severity of frontal fibrosing alopecia, a scarring form of alopecia marked by hairline recession and eyebrow loss primarily affecting postmenopausal women.
As regulatory demands and office expenses increase, insurance reimbursement seems flat or on a slow decline, says Howard Wooding Rogers, M.D.
Physicians may want to reconsider goals for the treatment of plaque psoriasis. In this study, physicians describe utilizing treat-to-target with a patient-centered approach to care for symptom relief.